RICCI, ANGELA DALIA

RICCI, ANGELA DALIA  

Mostra records
Risultati 1 - 20 di 61 (tempo di esecuzione: 0.05 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issue Brandi G.; Deiana C.; Galvani L.; Palloni A.; Ricci A.D.; Rizzo A.; Tavolari S. 2023-01-01 FRONTIERS IN ONCOLOGY - 1.01 Articolo in rivista Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma.pdf
The Potential Role of Adjuvant Chemoradiotherapy in Patients with Microscopically Positive (R1) Surgical Margins after Resection of Cholangiocarcinoma Palloni, Andrea; Bisello, Silvia; Maggio, Ilaria; Massucci, Maria; Galuppi, Andrea; Di Federico, ...Alessandro; Rizzo, Alessandro; Ricci, Angela Dalia; Siepe, Giambattista; Morganti, Alessio Giuseppe; Brandi, Giovanni; Frega, Giorgio 2023-01-01 CURRENT ONCOLOGY - 1.01 Articolo in rivista curroncol-30-00358.pdfcurroncol-30-00358-s001.zip
Assessment of the Risk of Nodal Involvement in Rectal Neuroendocrine Neoplasms: The NOVARA Score, a Multicentre Retrospective Study Ricci A.D.; Pusceddu S.; Panzuto F.; Gelsomino F.; Massironi S.; De Angelis C.G.; Modica R.; Ricc...o G.; Torchio M.; Rinzivillo M.; Prinzi N.; Rizzi F.; Lamberti G.; Campana D. 2022-01-01 JOURNAL OF CLINICAL MEDICINE - 1.01 Articolo in rivista jcm-11-00713-v2.pdf
Atezolizumab-bevacizumab plus Y-90 TARE for the treatment of hepatocellular carcinoma: preclinical rationale and ongoing clinical trials Di Federico A.; Rizzo A.; Carloni R.; De Giglio A.; Bruno R.; Ricci D.; Brandi G. 2022-01-01 EXPERT OPINION ON INVESTIGATIONAL DRUGS - 1.01 Articolo in rivista -
Combining immune checkpoint inhibitors with locoregional therapies in hepatocellular carcinoma Rizzo A.; Ricci A.D.; Brandi G. 2022-01-01 EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT - 1.01 Articolo in rivista -
Dual immune checkpoint blockade in hepatocellular carcinoma: where do we stand? Riccardo Carloni, Alessandro Rizzo, Angela Dalia Ricci, Giorgio Frega, Alessandro Di Federico, An...drea Palloni, Mariacristina Di Marco, Gennaro Gadaleta-Caldarola, Giovanni Brandi 2022-01-01 FUTURE ONCOLOGY - 1.01 Articolo in rivista -
Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes Di Federico A.; Mosca M.; Pagani R.; Carloni R.; Frega G.; De Giglio A.; Rizzo A.; Ricci D.; Tavo...lari S.; Di Marco M.; Palloni A.; Brandi G. 2022-01-01 CANCERS - 1.01 Articolo in rivista articolo 2022 Immunotherapy in Pancreatic Cancer Why Do We Keep Failing A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes.pdf
Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumour Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes Alessandro Di Federico, Mirta Mosca, Rachele Pagani, Riccardo Carloni, Giorgio Frega, Andrea De G...iglio, Alessandro Rizzo, Dalia Ricci, Simona Tavolari, Mariacristina Di Marco, Andrea Palloni, Giovanni Brandi. 2022-01-01 CANCERS - 1.01 Articolo in rivista cancers-14-02429 (1).pdf
Impact of clinicopathological features on immune-based combinations for advanced urothelial carcinoma: A meta-analysis Rizzo A.; Mollica V.; Santoni M.; Ricci A.D.; Gadaleta-Caldarola G.; Montironi R.; Massari F. 2022-01-01 FUTURE ONCOLOGY - 1.01 Articolo in rivista -
Lenvatinib plus pembrolizumab: the next frontier for the treatment of hepatocellular carcinoma? Rizzo A.; Dadduzio V.; Ricci A.D.; Massari F.; Di Federico A.; Gadaleta-Caldarola G.; Brandi G. 2022-01-01 EXPERT OPINION ON INVESTIGATIONAL DRUGS - 1.01 Articolo in rivista -
Platinum-based adjuvant chemotherapy for upper tract urothelial carcinoma: a change of paradigm? A meta-analysis of aggregate data Ricci A.D.; Rizzo A.; Mollica V.; Schiavina R.; Fiorentino M.; Brunocilla E.; Ardizzoni A.; Massa...ri F. 2022-01-01 ANTI-CANCER DRUGS - 1.01 Articolo in rivista -
Systemic Treatment for Metastatic Biliary Tract Cancer: State of the Art and a Glimpse to the Future Rizzo A.; Ricci A.D.; Cusmai A.; Acquafredda S.; De Palma G.; Brandi G.; Palmiotti G. 2022-01-01 CURRENT ONCOLOGY - 1.01 Articolo in rivista Systemic Treatment for Metastatic Biliary Tract Cancer.pdf
The Impact of Concomitant Proton Pump Inhibitors on Immunotherapy Efficacy Among Patients with Urothelial Carcinoma: A Meta-Analysis Rizzo A.; Santoni M.; Mollica V.; Ricci A.D.; Calabro C.; Cusmai A.; Gadaleta-Caldarola G.; Palmi...otti G.; Massari F. 2022-01-01 JOURNAL OF PERSONALIZED MEDICINE - 1.01 Articolo in rivista JPM 2022_[Rizzo PPI].pdfjpm-12-00842-s001.zip
Atezolizumab in advanced hepatocellular carcinoma: Good things come to those who wait Rizzo A.; Ricci A.D.; Brandi G. 2021-01-01 IMMUNOTHERAPY - 1.01 Articolo in rivista -
Bayesian Analysis Supports Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma Rizzo A.; Ricci A.D.; Brandi G. 2021-01-01 LIVER CANCER - 1.01 Articolo in rivista Bayesian Analysis Supports.pdf
Bone targeting agents in patients with metastatic prostate cancer: State of the art Mollica V.; Rizzo A.; Rosellini M.; Marchetti A.; Ricci A.D.; Cimadamore A.; Scarpelli M.; Bonucc...i C.; Andrini E.; Errani C.; Santoni M.; Montironi R.; Massari F. 2021-01-01 CANCERS - 1.01 Articolo in rivista Cancers 2021 [Bone Mets].pdf
Combination therapy of dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer Rizzo A.; Ricci A.D.; Brandi G. 2021-01-01 HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL - 1.04 Replica / breve intervento (e simili) -
Comparative effectiveness of first-line immune checkpoint inhibitors plus tyrosine kinase inhibitors according to IMDC risk groups in metastatic renal cell carcinoma: A meta-analysis Rizzo A.; Mollica V.; Santoni M.; Rosellini M.; Marchetti A.; Ricci A.D.; Grilli G.; Greco A.; Mo...ntironi R.; Ardizzoni A.; Massari F. 2021-01-01 IMMUNOTHERAPY - 1.01 Articolo in rivista -
Detecting and targeting NTRK gene fusions in cholangiocarcinoma: news and perspectives Rizzo A.; Ricci A.D.; Brandi G. 2021-01-01 EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT - 1.01 Articolo in rivista -
DNA damage response alterations in gastric cancer: Knocking down a new wall Ricci A.D.; Rizzo A.; Brandi G. 2021-01-01 FUTURE ONCOLOGY - 1.01 Articolo in rivista -